Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03024996
Brief Title: A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy (IMmotion010)

First Submitted : January 17, 2017
First Submitted that Met QC Criteria : January 17, 2017
First Posted : January 19, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : October 7, 2019
Last Update Posted : October 8, 2019